Peptide Cancer Vaccine Market Revenue 2024 to 2034
Peptide Cancer Vaccine Market Revenue 2024 to 2034
The Peptide Cancer Vaccine Market is projected to expand from USD 29.55 Bn in 2024 to USD 107.38 Bn by 2034, at a CAGR of 13.7%. Growth is fueled by rising cancer incidence, advances in immunotherapy, and increasing adoption of personalized peptide-based treatments worldwide.
Report ID: 10340
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 29.55 Bn
Forecast Year,
USD 107.38 Bn
CAGR, 2025 -
13.77%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Peptide Cancer Vaccine Market Size Analysis
Peptide Cancer Vaccine Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 9.46 | 10.77 | 12.21 | 13.83 | 15.58 | 17.83 | 20.25 | 23.07 | 26.21 | 29.80 | 33.91 |
| Biologics | 10.05 | 11.40 | 13.01 | 14.89 | 17.07 | 19.30 | 22.04 | 25.02 | 28.41 | 32.28 | 36.64 |
| Advanced Therapies | 5.32 | 6.07 | 6.91 | 7.90 | 9.02 | 10.27 | 11.67 | 13.31 | 15.18 | 17.26 | 19.69 |
| Others | 4.73 | 5.37 | 6.12 | 6.89 | 7.83 | 8.93 | 10.12 | 11.51 | 13.15 | 15.04 | 17.14 |
Peptide Cancer Vaccine Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 10.64 | 12.12 | 13.73 | 15.64 | 17.76 | 20.18 | 23.04 | 26.16 | 29.75 | 33.87 | 38.48 |
| Cardio-Metabolic | 5.32 | 6.02 | 6.83 | 7.79 | 8.89 | 10.16 | 11.48 | 13.07 | 14.96 | 17.08 | 19.55 |
| Infectious | 4.73 | 5.37 | 6.18 | 7.04 | 8.02 | 9.13 | 10.43 | 11.84 | 13.40 | 15.20 | 17.34 |
| CNS | 4.14 | 4.74 | 5.41 | 6.15 | 7.04 | 8.00 | 9.02 | 10.30 | 11.71 | 13.34 | 15.12 |
| Others | 4.73 | 5.36 | 6.10 | 6.90 | 7.80 | 8.87 | 10.11 | 11.54 | 13.14 | 14.89 | 16.89 |
Peptide Cancer Vaccine Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 13.00 | 14.84 | 16.85 | 19.20 | 21.90 | 24.92 | 28.36 | 32.21 | 36.60 | 41.63 | 47.56 |
| Retail Pharmacy | 10.64 | 12.07 | 13.76 | 15.68 | 17.87 | 20.41 | 23.26 | 26.47 | 30.11 | 34.33 | 38.83 |
| Online/Other | 5.91 | 6.72 | 7.64 | 8.63 | 9.74 | 10.99 | 12.47 | 14.23 | 16.25 | 18.42 | 20.98 |
Peptide Cancer Vaccine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 11.82 | 13.55 | 15.44 | 17.61 | 19.99 | 22.75 | 25.92 | 29.41 | 33.63 | 38.30 | 43.57 |
| Europe | 8.27 | 9.37 | 10.70 | 12.12 | 13.84 | 15.69 | 17.82 | 20.45 | 23.16 | 26.28 | 29.83 |
| Asia Pacific | 7.09 | 8.01 | 9.05 | 10.30 | 11.72 | 13.37 | 15.18 | 17.16 | 19.50 | 22.20 | 25.36 |
| Latin America | 1.18 | 1.33 | 1.52 | 1.74 | 1.97 | 2.24 | 2.57 | 2.93 | 3.30 | 3.77 | 4.27 |
| Middle East & Africa | 1.18 | 1.35 | 1.54 | 1.75 | 1.99 | 2.27 | 2.59 | 2.96 | 3.36 | 3.83 | 4.34 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
